EP
ETNB

Eversept Partners’s 89bio ETNB Stock Holding History

Eversept Partners’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-392,441
Closed -$5.77M – 109
2025
Q3 		$5.77M Buy
392,441
+156,451
+66% +$1.59M 0.4% 48
2025
Q2 		$2.32M Sell
235,990
-67,741
-22% -$561K 0.21% 50
2025
Q1 		$2.21M Buy
+303,731
New +$2.66M 0.22% 43

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Eversept Partners's ETNB Position: Q4 2025 in Review

Eversept Partners sold out of 89bio (ETNB) in Q4 2025, closing a stake of 392,441 shares — an estimated $5.77M sold.

Eversept Partners first reported a position in ETNB in Q1 2025 and held it in 3 quarters. The position peaked at $5.77M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Eversept Partners reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Eversept Partners sold 392,441 89bio shares in Q4 2025, an estimated $5.77M.
  • Eversept Partners first reported a position in 89bio in Q1 2025 and held it in 3 quarters.
  • Eversept Partners's 89bio position peaked at $5.77M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Eversept Partners's 13F filing for Q4 2025, filed 17 Feb 2026.